• Ajoutez une description, des images, des menus et des liens à votre méga-menu

  • Une colonne sans paramètres peut être utilisée comme un espaceur

  • Lien vers vos collections, vos ventes et même des liens externes

  • Ajoutez jusqu'à cinq colonnes

  • The Maternova team is reposting this compelling four-part series by Dr. Harman Boparai with the persmission from [Global Pulse](http://www.globalpost.com/dispatches/globalpost-blogs/global-pulse/india-children-dying)

    BOSTON — On the second day of clinical rotations during my medical training in India in 2008, I found myself in the pediatric intensive care unit. Four-month old Dhruv lay in his bed fighting for his life with severe pneumonia. His breaths came fast and in grunts, as his rib muscles stretched in gasps from the effort. He had been brought from a nearby village and needed emergency care. We started intravenous antibiotics, but with the only two mechanical ventilators at the hospital already in use, I had to put a hand-held self-inflating bag on his face to help him breathe. He opened his eyes a few times and closed them, but after a while he seemed to breathe easier.

    I went home late that night after handing over his care, and when I returned the next morning I found that the pneumonia had taken Dhruv. But was it really the pneumonia? Or was it the fact that his parents, both migrant laborers, were uneducated, poor and could not afford to bring him to the city hospital in time? Or maybe the fact that we had only two ventilators, both unavailable? And this was Punjab, one of the more affluent states in India.

    Despite being hailed as an economic miracle, India’s rapid growth has failed to bring about corresponding gains in controlling child mortality. India still accounts for one-fourth of the world’s child mortality. Of the 27 million children born in India each year, nearly 2 million never make it to their fifth birthdays.

    (Emily Judem/GlobalPost)

    Just like Dhruv, nearly half of these children die from easily preventable causes like pneumonia and diarrhea. The heaviest burden of these deaths is borne by the poorest in the population, with wide differences among socioeconomic groups in access to, and use of, essential health services.

    In my final year of medical schooling, I found myself at Massachusetts General Hospital, passing through another ICU during a rotation with the department of anesthesiology and critical care. A respiratory therapist assisted a patient in a state of the art facility, complete with modern ventilators, cardiac monitors and a web of intravenous lines, feeding tubes, suction pumps and drains. But India and the United States are worlds apart, with the US under-five mortality rate at 8 deaths per 1000 births, in comparison to 61 in India. According to The World Bank, the United States spends more than $8,500 per capita on health care — more than any other country in the world. India spends $59.

    India has managed to decrease its number of child deaths from 3 million in 1990 to 1.7 million in 2011, an annual reduction rate of almost 3 percent. But even at this rate, India is not on course to meet Millennium Development Goal 4, which aims to reduce child deaths by two-thirds from 1990 levels. Further, the numbers hide major inequities among the urban and rural populations and the fact that most of these deaths are concentrated in the lowest economic quintiles.

    With this in mind, I travel from New York to India to report on what is being done on the ground to tackle the problem and to talk to the families who bear the real cost of losing these children. I will travel to the central state of Madhya Pradesh, to the district of Panna. Famous for its diamond mines and its tiger reserve, Panna also has the unenviable distinction of having among the highest child mortality rates in the country; out of every 1,000 live births, 140 children die. The fact remains that most of these lives can be saved with vaccines, adequate nutrition and basic medical and maternal care.

    Please join me as I journey to the heartland of India, to get to the root of the issues that are deciding the fate of its children.


    World Pulse Editor's Note: This is the first in a series of posts about child health in India, where, in 2011, 1.7 million children under the age of 5 died. Health reporting fellow Harman Boparai travels to India, where he once practiced as a physician, to take a deeper look at child health in his home country. "A Doctor's Notes" is part of a GlobalPost Special Report titled "The Seven Million," about the many challenges faced worldwide in an effort to reduce child mortality.
    http://www.globalpost.com/dispatches/globalpost-blogs/global-pulse/india-children-dying

    Note that a later post in this four part series will follow the newborn twins, Pooja 1 and Pooja 2--this is their home!

    Laisser un commentaire

    Les commentaires sont approuvés avant leur publication.


    Voir l'article entier

    Medical Devices for Hospitals and NGOs: How to Source the Right products for Maternal and Newborn Care
    Dispositifs médicaux pour les hôpitaux et les ONG : comment acheter les bons produits pour les soins maternels et néonatals

    juin 30, 2026 13 lire la lecture

    Voir l'article entier
    The High Quality Maternova Non-pneumatic anti-shock garment (NASG)
    Le vêtement antichoc non pneumatique (NASG) Maternova de haute qualité

    mai 25, 2026 1 lire la lecture

    Des vêtements antichoc non-pneumatiques (NASG) de haute qualité, conformes à la norme ISO 13485 et marqués CE, produits par Maternova pour être utilisés par les sages-femmes et les obstétriciens du monde entier afin de sauver des vies menacées par l'hémorragie post-partum. Nos NASG respectent les normes les plus strictes et sont approuvés par des centaines de cliniciens.

    Voir l'article entier
    A $.03 pill that could prevent maternal deaths; Part 4
    Une pilule à 0,03 $ qui pourrait prévenir les décès maternels ; 4ème partie

    mai 25, 2026 3 lire la lecture

    L'USPSTF, l'ACOG, la Society for Maternal-Fetal Medicine et la FIGO recommandent toutes l'aspirine à faible dose (LDA) pour les grossesses à haut risque. Les obstacles sont systémiques, comportementaux et structurels.

    Voir l'article entier